Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 32Recruiting 9Terminated 7Withdrawn 3Active not recruiting 3Unknown 2Not yet recruiting 2

Sponsor Class

OTHER 117INDUSTRY 101NIH 23NETWORK 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Dermatologic 3

Conditions

Breast Neoplasms 19Prostatic Neoplasms 15Multiple Myeloma 15Carcinoma, Non-Small-Cell Lung 12Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 9Leukemia, Myeloid, Acute 7Lung Neoplasms 6Leukemia, Biphenotypic, Acute 6Squamous Cell Carcinoma of Head and Neck 5Neuroblastoma 5Medulloblastoma 5Lymphoma, Mantle-Cell 5Leukemia 5Hodgkin Disease 5Ependymoma 5Colorectal Neoplasms 5Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Burkitt Lymphoma 4Wilms Tumor 3Urinary Bladder Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Oligodendroglioma 3Melanoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

encorafenib 1binimetinib 1Watchful Waiting 1Observation 1Nivolumab 1Ipilimumab 1Introns 1Interferon-alpha 1Interferon alpha-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Melanoma × Clear all
NCT00003641 2026-02-25

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
1,150 enrolled 6 charts
Dermatologic

Melanoma

NCT03235245 2025-08-01

EBIN

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
271 enrolled
Dermatologic

Melanoma

NCT01942603 2023-11-28

Minitub

European Organisation for Research and Treatment of Cancer - EORTC

Active not recruiting
296 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡